Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 451975, 12 pages
http://dx.doi.org/10.1155/2013/451975
Research Article

Analysis of Therapeutic Effect of Ilex hainanensis Merr. Extract on Nonalcoholic Fatty Liver Disease through Urine Metabolite Profiling by Ultraperformance Liquid Chromatography/Quadrupole Time of Flight Mass Spectrometry

1State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China
2School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China

Received 3 May 2013; Revised 16 July 2013; Accepted 17 July 2013

Academic Editor: Chun Tao Che

Copyright © 2013 Jing-jing Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. J. de Wit, L. A. Afman, M. Mensink et al., “Phenotyping the effect of diet on non-alcoholic fatty liver disease,” Journal of Hepatology, vol. 57, no. 6, pp. 1370–1373, 2012. View at Google Scholar
  2. H. Li, L. Wang, X. Yan et al., “A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease,” Journal of Proteome Research, vol. 10, no. 6, pp. 2797–2806, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Barr, M. Vázquez-Chantada, C. Alonso et al., “Liquid chromatography—mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease,” Journal of Proteome Research, vol. 9, no. 9, pp. 4501–4512, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. W. B. Salt II, “Nonalcoholic fatty liver disease (NAFLD): a comprehensive review,” Journal of Insurance Medicine, vol. 36, no. 1, pp. 27–41, 2004. View at Google Scholar · View at Scopus
  5. Y. Gao, L.-X. Song, M.-N. Jiang, G.-Y. Ge, and Y.-J. Jia, “Effects of traditional Chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis,” Inflammation, vol. 31, no. 2, pp. 121–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. W. X. Zhao, X. Y. Liu, R. Z. Duan et al., “Effect of Xiaozhihugan capsule on pathologic changes and CYP2E1 gene expression of rats with non-alcoholic fatty liver,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 22, no. 6, pp. 363–366, 2007. View at Google Scholar
  7. Department of Health of Guangxi Zhuang Minority Autonomous Region, Chinese Medicinal Materials Standard of Guangxi, Guangxi Science and Technology Press, Nanning, China, 1990.
  8. C. L. Hang and Q. R. Cao, “Tea-based Traditional Chinese medicine resource-Shanlvcha,” Journal of Chinese Medicinal Materials, no. 3, pp. 18–36, 1984. View at Google Scholar
  9. X. L. Wei, X. Q. Chen, R. T. Fang et al., “Preventive effects of flavonoid extracts from Ilex hainanensis Merr. on rats with hepatic steatosis induced by a high-fat diet,” Drug Development Research, vol. 73, no. 8, pp. 308–316, 2012. View at Google Scholar
  10. X.-Q. Chen, K. Zan, H. Liu, J. Yang, M.-X. Lai, and Q. Wang, “Triterpenes and flavonoids from Ilex hainanensis Merr. (Aquifoliaceae),” Biochemical Systematics and Ecology, vol. 37, no. 5, pp. 678–682, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S.-X. Zhou, J.-S. Yang, F.-C. Liu, and P.-F. Tu, “Triterpenoids from the leaves of Ilex hainanensis,” Helvetica Chimica Acta, vol. 90, no. 1, pp. 121–127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. K. Nicholson, J. C. Lindon, and E. Holmes, ““Metabonomics”: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data,” Xenobiotica, vol. 29, no. 11, pp. 1181–1189, 1999. View at Google Scholar · View at Scopus
  13. J. K. Nicholson, J. Connelly, J. C. Lindon, and E. Holmes, “Metabonomics: a platform for studying drug toxicity and gene function,” Nature Reviews Drug Discovery, vol. 1, no. 2, pp. 153–161, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. G. A. N. Gowda, S. Zhang, H. Gu, V. Asiago, N. Shanaiah, and D. Raftery, “Metabolomics-based methods for early disease diagnostics,” Expert Review of Molecular Diagnostics, vol. 8, no. 5, pp. 617–633, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Kaddurah-Daouk, B. S. Kristal, and R. M. Weinshilboum, “Metabolomics: a global biochemical approach to drug response and disease,” Annual Review of Pharmacology and Toxicology, vol. 48, pp. 653–683, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Jiang, W. Dai, S. Yan et al., “Biomarkers in the early period of acute myocardial infarction in rat serum and protective effects of Shexiang Baoxin Pill using a metabolomic method,” Journal of Ethnopharmacology, vol. 138, no. 2, pp. 530–536, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Yang, A. Zhang, H. Sun et al., “Metabolomic study of insomnia and intervention effects of Suanzaoren decoction using ultra-performance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 58, no. 1, pp. 113–124, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. G. G. Tan, W. T. Liao, X. Dong et al., “Metabonomic profiles delineate the effect of traditional Chinese medicine Sini decoction on myocardial infarction in rats,” PLoS ONE, vol. 7, no. 4, Article ID e34157, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. H. Zhang, H. Sun, X. H. Wu et al., “Urine metabolomics,” Clinica Chimica Acta, vol. 414, no. 24, pp. 65–69, 2012. View at Google Scholar
  20. X. Z. Hong, L. D. Li, and L. M. Wu, “Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease,” Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 1-2, pp. 27–35, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Li, T. A. Robertson, C. A. Thorling et al., “Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis,” Drug Metabolism and Disposition, vol. 39, no. 4, pp. 571–579, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Lv, X. Liu, S. Yan et al., “Metabolomic study of myocardial ischemia and intervention effects of Compound Danshen Tablets in rats using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 52, no. 1, pp. 129–135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S.-H. Kim, S.-O. Yang, H.-S. Kim, Y. Kim, T. Park, and H.-K. Choi, “1H-nuclear magnetic resonance spectroscopy-based metabolic assessment in a rat model of obesity induced by a high-fat diet,” Analytical and Bioanalytical Chemistry, vol. 395, no. 4, pp. 1117–1124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Bringolf, N. Zaragoza, D. Rivier, and J. P. Felber, “Studies on the metabolic effects induced in the rat by a high-fat diet. Inhibition of pyruvate metabolism in diaphragm in vitro and its relation to the oxidation of fatty acids,” European Journal of Biochemistry, vol. 26, no. 3, pp. 360–367, 1972. View at Google Scholar · View at Scopus
  25. E. K. Daugherity, G. Balmus, A. Al Saei et al., “The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease,” Cell Cycle, vol. 11, no. 10, pp. 1918–1928, 2012. View at Google Scholar
  26. J. B. Walker, “Metabolic control of creatine biosynthesis—II. Restoration of transamidinase activity following creatine repression,” The Journal of Biological Chemistry, vol. 236, pp. 493–498, 1961. View at Google Scholar · View at Scopus
  27. B. G. Xie, M. J. Waters, and H. J. Schirra, “Investigating potential mechanisms of obesity by metabolomics,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 805683, 10 pages, 2012. View at Publisher · View at Google Scholar
  28. F. Konishi, “The relationship of urinary 17-hydroxycorticosteroids to creatinine in obesity,” Metabolism, vol. 13, no. 9, pp. 847–851, 1964. View at Google Scholar · View at Scopus
  29. H. J. Schirra, C. G. Anderson, W. J. Wilson et al., “Altered metabolism of growth hormone receptor mutant mice: a combined NMR metabonomics and microarray study,” PLoS ONE, vol. 3, no. 7, Article ID e2764, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Satoh, “Cardioprotective actions of taurine against intracellular and extracellular calcium-induced effects,” Advances in Experimental Medicine and Biology, vol. 359, pp. 181–196, 1994. View at Google Scholar · View at Scopus
  31. M. S. Klein, C. Dorn, M. Saugspier, C. Hellerbrand, P. J. Oefner, and W. Gronwald, “Discrimination of steatosis and NASH in mice using nuclear magnetic resonance spectroscopy,” Metabolomics, vol. 7, no. 2, pp. 237–246, 2011. View at Publisher · View at Google Scholar · View at Scopus